Discover Prospects for Medical Research and Therapeutic Uses, Including Human Tissues, Stem Cells (Adult Stem Cells, Umbilical Cord), Other applications (DNA, RNA, body fluids), Leading Biobanking Companies and Key Geographies
Biobanking – our new study reveals trends, R&D progress, and predicted revenues Where is the Biobanking market heading? If you are involved in this sector you must read this brand-new report. Visiongain’s report shows you the potential revenues streams to 2028, assessing data, trends, opportunities and business prospects there.
Discover How to Stay Ahead Our 266-page report provides 145 tables, charts, clearly illustrating the data presented in this research. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted drug sales at overall world market regional level, as well as giving a deep insight into the pipeline for Biobanking. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Biobanking market. See how to exploit these opportunities.
Forecasts to 2028 and other analyses reveal the commercial prospects • In addition to revenue forecasting to 2028, our new study provides you with recent results, R&D overview, growth rates, and market shares. • You will find original analyses, with business outlooks and developments. • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and following Biobanking Submarkets:
• Biobanking for Research: • Human Tissue: – Commercial – Public • Stem Cells • Others (DNA, Blood fluids etc.)
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 12 leading national markets: • US • Germany • France • The UK • Spain • Italy • The Netherlands • Japan • China • India • Brazil • Russia • RoW
Our analysis shows activities of biobanks, including these organisations: • Stemgent • Biopta • BioServe • Coriell Institute for Medical Research • Cord Blood America • Cryo-Cell International.
And other companies, including these: • China Cord Blood Corp • LifebankUSA • ViaCord • Cord Blood Registry • Biogenea Pharmaceuticals • StemLife • Caladrius Biosciences.
There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, China, India and the US in particular, will continue to achieve high revenue growth to 2028.
Leading companies and the potential for market growth Overall world revenue for Biobanking will surpass $35bn in 2023, our work calculates. This will be driven by the use of biobanking in drug development and medical research, as well as the expected rise in number of commercial biobanks over the forecast period
Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Biobanking Market report helps you In summary, our 266-page report provides you with the following knowledge: • Revenue forecasts to 2028 for the Biobanking market and Leading Submarkets – discover the industry’s prospects, finding the most lucrative places for investments and revenues • Revenue forecasts to 2028 for 12 of the leading national markets – US, Germany, France, UK, Italy, Spain, Netherlands, Japan, Russia, China, India, Brazil • Discussion of what stimulates and restrains companies and the market • Prospects for established firms and those seeking to enter the market – including company profiles for 16 companies involved in commercial biobanking and biobanking for therapeutic use
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.
Visiongain’s study is for everybody needing commercial analyses for the Biobanking market and leading companies. You will find data, trends and predictions.
Get our report today Biobanking Market Analysis : Discover Prospects for Medical Research and Therapeutic Uses, Including Human Tissues, Stem Cells (Adult Stem Cells, Umbilical Cord), Other applications (DNA, RNA, body fluids), Leading Biobanking Companies and Key Geographies. Avoid missing out – get our report now.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
1. Report Overview
1.1 Biobanking for Medicine: World Market Review 2017 and Global Segmentation
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Key Questions Answered by This Analytical Report
1.5 Who is This Report For?
1.6 Methodology
1.7 Frequently Asked Questions (FAQ)
1.8 Associated Visiongain Reports
1.9 About Visiongain
2. Introduction to Biobanking and its Applications
2.1 Defining the Human Tissue Banking Market for the Scope of this Report
2.2 The Stem Cell Banking Market – Our Breakdown
2.3 What is Biobanking?
2.4 Main Features of Biobanks
2.5 What Processes are Involved in Biobanking?
2.6 Classification of Biobanks: Tissue Type, Volunteer Group and Ownership Classification Models
2.6.1 Volunteer Group: General vs. Disease Population
2.6.2 Ownership Structure: Public vs. Private
2.7 The Guidelines and Standards for Biobanking
2.8 Laws and Regulations for Biobank-Based Research
2.8.1 HIPAA Amendments
2.9 Biobanking and the Pharmaceutical Industry
2.9.1 Biobanking in Research, Drug Discovery and Development
Table 2.3 Guidelines and Recommendations for Biobanks, 2018
Table 2.4 Laws and Other Regulations for Biobank-Based Research by Country/ Organisation 2018
Table 2.5 Pharmaceutical and Biotechnology Companies with In-House Biobanks, 2018
Table 3.1 Breakdown of the Biobanking Industry by Research vs. Therapeutics: Revenue ($bn) and Market Share (%), 2018
Table 3.2 Biobanking for Medicine: Research vs. Therapeutics in 2023 and 2028
Table 3.3 Biobanking for Medicine: Overall World Forecast, Revenue ($bn), Annual Growth (%), CAGR (%), 2018 to 2028
Table 3.4 The No. of Samples Stored in Biobanks by Purpose: Overall World Forecast No. Of Samples (Bn), Annual Growth (%), CAGR (%), 2018 to 2028
Table 3.5 Biobanking for Medicine by Sector: Grouped Forecasts, Revenue ($bn), Annual Growth (%), CAGR (%), 2018 to 2028
Table 3.6 Biobanking Market for Research Forecast: Revenue ($bn), Market Share (%), Annual Growth (%), CAGR (%), 2018 to 2028
Table 3.7 Biobanking for Therapeutic Use Forecast: Revenue ($bn), Market Share (%), Annual Growth (%), CAGR (%), 2018 to 2028
Table 4.1 The Biobanking for Research Market by Tissue Type: Revenues ($bn) and Market Shares (%), 2018
Table 4.2 Biobanking for Research by Tissue Type: A Comparison of Revenues ($bn) and Market Shares (%), 2023 and 2028
Table 4.3 Biobanking for Research by Tissue Type: Grouped Forecasts, Revenue ($bn), Annual Growth (%), CAGR (%), 2018 to 2028
Table 4.4 Number of Research Samples Banked: Overall World Forecast, No. of Samples (m), Annual Growth (%), CAGR (%), 2018 to 2028
Table 4.5 The Human Tissue Banking Market Forecast: Revenue ($bn), Market Share (%) Annual Growth (%), CAGR (%), 2018 to 2028
Table 4.6 The Commercial vs. Public Sector Human Tissue Banking Market: Comparison of Revenues ($bn) and Market Share (%), 2018, 2023 and 2028
Table 4.7 Commercial Human Tissue Banking Forecast, Revenue ($bn) Annual Growth (%), CAGR (%), 2018 to 2028
Table 4.8 Commercial Human Tissue Banking Forecast: Revenue ($bn), Market Share (%), Annual Growth (%), CAGR (%), 2018 to 2028
Table 4.9 Prominent Commercial Human Tissue Banks, 2018
Table 4.10 Public Sector Human Tissue Banking Forecast: Revenue ($bn), Market Share (%) Annual Growth (%), CAGR (%), 2018 to 2028
Table 4.11 Prominent Public-Funded Human Tissue Banks, 2018
Table 4.12 The Stem Cell Banking Market for Research Forecast: Revenue ($bn), Market Share (%), Annual Growth (%), CAGR (%), 2018 to 2028
Table 4.13 Prominent Stem Cell Banks Serving the Research Community, 2018
Table 4.14 Banking of Other Biologic Specimens for Research Forecast: Revenue ($bn), Market Share (%), Annual Growth (%), CAGR (%), 2018 to 2028
Table 4.15 Prominent Biobanks Storing Other Biologic Samples, 2018
Table 5.1 Biobanking for Therapeutic Use by Stem Cell Type: Market Share (%), 2018
Table 5.2 Biobanking for Therapeutic Use by Stem Cell Type: Comparison of Revenues ($bn) and Market Share (%), 2023 and 2028
Table 5.3 Number of Research Samples Banked: Overall World Forecast, No. of Samples (m), Annual Growth (%), CAGR (%), 2018 to 2028
Table 5.4 The Number of Stem Cell Samples Banked for Therapeutic Use: Overall World Forecast, No. of Samples (m), Annual Growth (%), CAGR (%), 2018 to 2028
Table 5.5 Prominent Public and Private Cord Blood Banks, 2018
The Alzheimer’s Disease Therapeutics and Diagnostics Market will reach $7.93bn in 2018. The Alzheimer’s Disease Therapeutics and Diagnostics Market is...
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The global AI-based Clinical Trial Solution Providers market was valued at US$1,232.0 million in 2022 and is projected to grow at a CAGR of 23.3% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
